Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 105
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04319783 | Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA | ||
| NCT04641013 | Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) | ||
| NCT05196789 | Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) | ||
| NCT05184790 | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | ||
| NCT05864742 | Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma | ||
| NCT07090369 | Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT01658241 | Panobinostat Biological Correlates Study | ||
| NCT03569072 | High Intensity Functional Image Guided Vmat Lung Evasion | ||
| NCT05560659 | Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy | ||
| NCT03429387 | PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia | ||
| NCT01742793 | An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study) | ||
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT03980171 | Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma | ||
| NCT04985721 | A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects | ||
| NCT03363867 | BEACON - ABC in Recurrent Platinum Resistant HGSOC | ||
| NCT05263700 | FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary | ||
| NCT02855203 | Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours | ||
| NCT05340374 | Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer | ||
| NCT05169177 | Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy | ||
| NCT06510699 | Pharmacogenomics for Better Treatment of Fungal Infections in Cancer | ||
| NCT03851146 | A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours | ||
| NCT05666700 | CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study | ||
| NCT02999893 | A Study of APR-246 in Oesophageal Cancer | ||
| NCT01493206 | A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer | ||
| NCT03307759 | Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma | ||
| NCT06127654 | Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy | ||
| NCT05899985 | Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation | ||
| NCT04234061 | Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma | ||
| NCT03464942 | Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer | ||
| NCT04343885 | In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy | ||
| NCT06082128 | FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers | ||
| NCT04534725 | COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; | ||
| NCT07051525 | Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever | ||
| NCT00206609 | The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer | ||
| NCT05366153 | Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer | ||
| NCT05053854 | PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours | ||
| NCT00234169 | A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone | ||
| NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | ||
| NCT05425862 | Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT02506556 | Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer | ||
| NCT00193934 | Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer | ||
| NCT07138222 | IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma | ||
| NCT06279260 | National Robotics-Assisted Radical Prostatectomy Database | ||
| NCT05983159 | A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations | ||
| NCT00434239 | Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia | ||
| NCT05095519 | Hepatocellular Carcinoma Imaging Using PSMA PET/CT | ||
| NCT00418210 | Accelerated Partial Breast Irradiation for Early Breast Cancer | ||
| NCT02662062 | Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer | ||
| NCT00482261 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | ||
| NCT04720768 | Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE |
